Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1

Blood

Volumn 100, Issue 5, 2002, Pages 1795-1801

  Pedersen, Irene M ^a,b,c   Kitada, Shinichi ^a,b,c   Leoni, Lorenzo M ^a,b,c   Zapata, Juan M ^a,b,c   Karras, James G ^a,b,c   Tsukada, Nobuhiro ^a,b,c   Kipps, Thomas J ^a,b,c   Choi, Yong Sung ^a,b,c   Bennett, Frank ^a,b,c   Reed, John C ^a,b,c  

^a BURNHAM INSTITUTE   (United States)

^b Ochsner for Children   (United States)

^c ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN BCL 2; PROTEIN MCL 1; VASCULAR ADHESION PROTEIN 1;

APOPTOSIS; ARTICLE; CELL INTERACTION; CELL PROTECTION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 0036720390     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v100.5.1795.h81702001795_1795_1801     Document Type: Article

References (56)

1. B-cell chronic lymphocytic leukemia: A bird of a different feather
2. Cancer statistics, 1995
3. Chronic lymphocytic leukemia: An accumulative disease of immunologically incompetent lymphocytes
4. B-cell chronic lymphocytic leukemia: Present status and future directions
5. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro
6. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells
7. Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia
8. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
9. Distinct role of follicular dendritic cells and T cells in the proliferation, differentiation, and apoptosis of a centroblast cell line, L3055
10. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
11. Stimulation of germinal center B lymphocyte proliferation by an FDC-like cell line, HK
12. Detection of multiple antigens on Western blots
13. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vlvo chemoresponses
14. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes
15. Immunohistochemical analysis of in vivo patterns of Bcl-X expression
16. Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma
17. Immunohistochemical analysis of in vivo patterns of Bak expression, a pro-apoptotic member of the Bcl-2 protein family
18. Expression and prognostic significance of IAP-family genes in human cancers and myeioid leukemias
19. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b
20. Activation and proliferation of follicular dendritic ceil-like cells by activated T lymphocytes
21. Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK
22. Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation
23. Chronic lymphoproliferative disorders
24. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia
25. B-chronic lymphocytic leukemia: A malignancy of anti-self B cells
26. Chronic lymphocytic leukemic B cells but not normal cells are rescued from apoptosis by contact with normal bone marrow stromal cells
27. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro
28. Biology of chronic lymphocytic leukemia
29. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1
30. Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1 and CD106 (VCAM-1)-dependent mechanism
31. Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma
32. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells
33. Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia
34. Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells
35. Follicular dendritic cells in non-Hodgkin's lymphomas
36. NF-KB-mediated up-regulation of bcl-x and bfl-1/a1 is required for CD40 survival signaling in B lymphocytes
37. Induction of Bcl-X by CD40 engagement rescues sig-induced apoptosis in murine B cells
38. Early lethality, functional NF-KB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
39. Regulation of BclxL: A little bit of this and a little bit of STAT
40. Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families
41. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB
42. IL-6 up-regulates mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway
43. Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils
44. Mcl-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2
45. The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2
46. Apoptosis regulation and Bcl-2 family gene expression in chronic lymphocytic leukemia
47. Mcl-1 deficiency results in peri-implantation embryonic lethality
48. Massive cell death of immature hematopoielic cells and neurons in Bcl-X-deficient mice
49. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
50. Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating Bcl-2 family protein function
51. L during apoptosis
52. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
53. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition
54. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: Upregulation of Bcl-xL and Mcl-1
55. Quiescent memory B cells in human peripheral blood co-express bcl-2 and bcl-x(L) anti-apoptotic proteins at high levels
56. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: Evidence of caspase activation and apoptosis induction